CD4 and neoplasm: Moreover, reinfusion of CD4+CD25+ T cells in tumor-bearing mice, pre-treated with low-dose cyclophosphamide, abrogated the anti-tumor effect of the drug, emphasizing that Tregs counteract the therapeutic efficacy of the drug (153).